ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

The Philadelphia Story: How Surprise Filing by Abramson Spurred Penn to Follow Suit

March 16, 2012

Unique Molecular Profile For Lung Cancer Described

March 31, 2006

New Reagan Budget Or FY 1982 gives NCI $1.026 Billion

March 6, 1981

Virus Studies Approved By DCE Board for $2.5 Mil. In First Year

November 3, 1989

Randomized Trial Finds Sunscreen Use Cuts Risk Of Developing Melanoma

December 31, 2010

NCI-Approved Cancer Center, Cooperative Group Trials

December 28, 2007